BioAge Labs, Inc. - Common Stock, par value $0.00001 per share (BIOA)

CUSIP: 09077V100

Q4 2024 13F Holders as of 31 Dec 2024

Security type / class
Equity / Common Stock, par value $0.00001 per share
Total 13F shares
19,641,111
Total 13F value
$113,720,000
Holder snapshot 6 signals
Share change
-1,081,730
SEC-reported price per share
$5.79
Number of holders
64
Value change
-$68,696,192
Number of buys
43
Number of sells
40
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
44,967,550

Security key

09077V100

Report period

Q4 2024

Institutions

64

Top holders

10

BIOA full security history Ownership snapshot Full 13F holder table Newer quarter: Q1 2025 Previous quarter: Q3 2024 BioAge Labs, Inc. SEC filings BioAge Labs, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of BIOA - BioAge Labs, Inc. - Common Stock, par value $0.00001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
RA CAPITAL MANAGEMENT, L.P.
Disclosed value leader
a16z Capital Management, ...
Comparable rows
15/15
Latest evidence
30 Sep 2024
13F 13D/G 3/4/5 Lead comparable stake: 3.7% 13D/G row: RA CAPITAL MANAGEMENT, L.P. Showing 1-6 of 15 holder rows.

Quick read

RA CAPITAL MANAGEMENT, L.P. leads the comparable SEC ownership view at 3.7%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens RA CAPITAL MANAGEMENT, L.P.'s linked filing trail.
Comparable ownership Top 5
RA CAPITAL MANAGEMENT, L.P. 3.7%
a16z Capital Management, L.L.C. 6.7%
Sofinnova Investments, Inc. 5.1%
Cormorant Asset Management, LP 3.6%
SUVRETTA CAPITAL MANAGEMENT, LLC 3.2%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
RA CAPITAL MANAGEMENT, L.P.
13F 13D/G
Company
13F 13D/G
3.7%
from 13D/G
$45,980,251
2,210,589 shares
 — 30 Sep 2024
a16z Capital Management, L.L.C.
13F
Company
13F
6.7%
$62,690,680
3,013,975 shares
 — 30 Sep 2024
Sofinnova Investments, Inc.
13F
Company
13F
5.1%
$47,941,941
2,304,901 shares
 — 30 Sep 2024
Cormorant Asset Management, LP
13F 3/4/5
Company · Former 10% Owner
13F 3/4/5
3.6%
$33,894,203
1,629,529 shares
 — 30 Sep 2024
SUVRETTA CAPITAL MANAGEMENT, LLC
13F
Company
13F
3.2%
$30,264,000
1,455,000 shares
 — 30 Sep 2024
ORBIMED ADVISORS LLC
13F
Company
13F
3.2%
$29,608,176
1,423,470 shares
 — 30 Sep 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
64
Shares
19,641,111
Rows available
64
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2024 vs Q3 2024 Across Filers

Q3 2024 holders
58
Q4 2024 holders
64
Holder diff
6
Investor Q3 2024 Shares Q4 2024 Shares Share Diff Share Chg % Q3 2024 value Q4 2024 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .